# IT Tech Packaging, Inc.: Form 10-Q for the period ended Sep 30, 2020

- Company: [IT Tech Packaging, Inc.](/companies/itp.md) (CIK 1358190)
- Form: 10-Q
- Filed: 2020-11-12
- Accepted by EDGAR: Nov 12, 2020, 09:28 ET
- Period: 2020-09-30
- Accession: 0001213900-20-036390
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1358190/000121390020036390/f10q0920_ittechpack.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1358190/000121390020036390/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $33.4m | us-gaap:Revenues |
| Revenue | 9 months, 2020-01-01 to 2020-09-30 | $68.5m | us-gaap:Revenues |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $2.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-01-01 to 2020-09-30 | $5.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $2.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $8.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | $176.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$3.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-07-01 to 2020-09-30 | $258.4k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-30 | $744.6k | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | $26.3k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | −$579.4k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$521.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$3.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.15 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $2.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $3.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-09-30 | $8.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $30.4m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $193.3m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $16.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $24.2m | us-gaap:Liabilities |
| Long-term debt | at 2020-09-30 | $9.2m | us-gaap:LongTermDebt |
| Shareholders' equity | at 2020-09-30 | $169.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 52,056 characters.

### Cautionary Notice Regarding Forward-Looking Statements

The following discussion of the financial condition and results of operations of the Company for the periods ended September 30, 2020 and 2019 should be read in conjunction with the financial statements and the notes to the financial statements that are included elsewhere in this quarterly report.

In this quarterly report, references to “the Company,” “we,” “our” and “us” refer to IT Tech Packaging, Inc. and its PRC subsidiary and variable interest entity unless the context requires otherwise.

We make certain forward-looking statements in this report. Statements concerning our future operations, prospects, strategies, financial condition, future economic performance (including growth and earnings), demand for our products, and other statements of our plans, beliefs, or expectations, including the statements contained under the captions “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as captions elsewhere in this document, are forward-looking statements. In some cases these statements are identifiable through the use of words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, “plan”, “project”, “target”, “can”, “could”, “may”, “should”, “will”, “would”, and similar expressions. We intend such forward-looking statements to be covered by the safe harbor provisions contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The forward-looking statements we make are not guarantees of future performance and are subject to various assumptions, risks, and other factors that could cause actual results to differ materially from those suggested by these forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. Indeed, it is likely that some of our assumptions may prove to be incorrect. Our actual results and financial position may vary from those projected or implied in the forward-looking statements and the variances may be material. You are cautioned not to place undue reliance on such forward-looking statements. These risks and uncertainties, together with the other risks described from time to time in reports and documents that we file with the Securities and Exchange Commission (the “SEC”) should be considered in evaluating forward-looking statements. In evaluating the forward-looking statements contained in this report, you should consider various factors, including, without limitation, the following: (a) those risks and uncertainties related to general economic conditions, (b) whether we are able to manage our planned growth efficiently and operate profitably, (c) whether we are able to generate sufficient revenues or obtain financing to sustain and grow our operations, and (d) whether we are able to successfully fulfill our primary requirements for cash. We assume no obligation to update forward-looking statements, except as otherwise required under federal securities laws.

### Results of Operations

### Comparison of the Three months ended September 30, 2020 and 2019

Revenue for the three months ended September 30, 2020 was $33,357,451, an increase of $419,534, or 1.27%, from $32,937,917 for the same period in the previous year.This was mainly due to the increase in sales volume of face mask, tissue paper products and corrugating medium paper (“CMP”).

#### Revenue of Offset Printing Paper, Corrugating Medium Paper and Tissue Paper Products

Revenue from sales of offset printing paper, CMP and tissue paper products for the three months ended September 30, 2020 was $33,136,349, an increase of $198,432, or 0.60%, from $32,937,917 for the third quarter of 2019. Total offset printing paper, CMP and tissue paper products sold during the three months ended September 30, 2020 amounted to 74,126 tonnes, an increase of 1,880 tonnes, or 2.60%, compared to 72,246 tonnes sold in the comparable period in the previous year. The changes in revenue dollar amount and in quantity sold for the three months ended September 30, 2020 and 2019 are summarized as follows:

| Sales Revenue | Three Months Ended September 30, 2020 Quantity (Tonne) | Amount | Three Months Ended September 30, 2019 Quantity (Tonne) | Amount | Change in Quantity (Tonne) | Amount | Percentage Change Quantity | Amount |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Regular CMP | 48,107 | $19,553,861 | 47,487 | $19,332,044 | 620 | $221,818 | 1.31% | 1.15% |
| Light-Weight CMP | 12,884 | $5,076,133 | 12,721 | $5,017,008 | 163 | $59,125 | 1.28% | 1.18% |
| **Total CMP** | 60,991 | $24,629,994 | 60,209 | $24,349,052 | 782 | $280,943 | 1.30% | 1.15% |
| Offset Printing Paper | 10,280 | $6,126,303 | 10,198 | $7,037,582 | 82 | $(911,279) | 0.80% | (12.95)% |
| Tissue Paper Products | 2,855 | $2,380,052 | 1,840 | $1,551,283 | 1,015 | $828,769 | 55.16% | 53.42% |
| **Total CMP, Offset Printing Paper and Tissue Paper Revenue** | 74,126 | $33,136,349 | 72,246 | $32,937,917 | 1,880 | $198,432 | 2.60% | 0.60% |

Monthly sales revenue for the 24 months ended September 30, 2020, are summarized below:

The Average Selling Prices (ASPs) for our main products in the three months ended September 30, 2020 and 2019 are summarized as follows:

|  | Offset Printing Paper ASP | Regular CMP ASP | Light-Weight CMP ASP | Tissue Paper Products ASP |
| --- | ---: | ---: | ---: | ---: |
| Three Months ended September 30, 2019 | $690 | $407 | $394 | $843 |
| Three Months ended September 30, 2020 | $596 | $406 | $394 | $834 |
| Decrease from comparable period in the previous year | $(94) | $(1) | $- | $(9) |
| Decrease by percentage | -13.62% | -0.25% | 0.00% | -1.07% |

26

The following chart shows the month-by-month ASPs for the 24-month period ended September 30, 2020:

#### Corrugating Medium Paper

Revenue from CMP amounted to $24,629,994 (74.33% of the total offset printing paper, CMP and tissue paper products revenues) for the three months ended September 30, 2020, representing an increase of $280,943, or 1.15%, from $24,349,052 for the comparable period in 2019.

We sold 60,991 tonnes of CMP in the three months ended September 30, 2020 as compared to 60,209 tonnes for the same period in 2019, representing a 1.30% increase in quantity sold

ASP for regular CMP dropped from $407/tonne for the three months ended September 30, 2019 to $406/tonne for the three months ended September 30, 2020, representing a 0.25% decrease. ASP in RMB for regular CMP for the third quarter of 2019 and 2020 was RMB2,846 and RMB2,816, respectively, representing a 1.05% decrease. The quantity of regular CMP sold increased by 620 tonnes, from 47,487 tonnes in the third quarter of 2019 to 48,107 tonnes in the third quarter of 2020.

ASP for light-weight CMP were $394/tonne for the three months ended September 30, 2019 and 2020. ASP in RMB for light-weight CMP for the third quarter of 2019 and 2020 was RMB2,758 and RMB2,727, respectively, representing a 1.12% decrease. The quantity of light-weight CMP sold increased by 163 tonnes, from 12,721 tonnes in the third quarter of 2019, to 12,884 tonnes in the third quarter of 2020.

Our PM6 production line, which produces regular CMP, has a designated capacity of 360,000 tonnes /year. The utilization rates for the third quarter of 2020 and 2019 were 53.77% and 53.19%, respectively, representing an increase of 0.58%.

Quantities sold for regular CMP that was produced by the PM6 production line from October 2018 to September 2020 are as follows:

#### Tissue Paper Products

We produce tissue paper products, including toilet paper, boxed and soft-packed tissues, handkerchief tissues and paper napkins, as well as bathroom and kitchen paper towels that are marketed and sold under the brand “Qingmu”. In December 2018 and November 2019, we completed the construction, installation and test of operation of our PM8 and PM9 production lines. We launched the complete line of processing base tissue paper with designated capacity of 15,000 tonnes/year, and producing finished tissue paper products with designated capacity of 15,000 tonnes/year.

Revenue from tissue paper products was $2,380,052 (7.18% of the total offset printing paper, CMP and tissue paper products revenues) for the three months ended September 30, 2020, representing an increase of $828,769, or 53.42%, from $1,551,283 for the three months ended September 30, 2019. We sold 2,855 tonnes of tissue paper in the third quarter of 2020, as compared to 1,840 tonnes in the comparable period of 2019, representing an increase of 1,015 tonnes, or 55.16%. Except for the production suspension in the first quarter of 2020, the production and sales of tissue paper products have been growing up steadily since the launch of PM8 and PM9 in December 2018 and November 2019.

ASP for tissue paper products decreased from $843/tonne for the three months ended September 30, 2019 to $834/tonne for the three months ended September 30, 2020, representing a 1.07% decrease. ASP in RMB for tissue paper products for the third quarter of 2019 and 2020 was RMB5,912 and RMB5,766, respectively, representing a 2.47% decrease. The quantity of tissue paper products sold increased by 1,015 tonnes, from 1,840 tonnes in the third quarter of 2019, to 2,855 tonnes in the third quarter of 2020.

#### Offset printing paper

Revenue from offset printing paper was $6,126,303 (18.49% of the total offset printing paper, CMP and tissue paper products revenues) for the three months ended September 30, 2020, representing a decrease of $911,279, or 12.95%, from $7,037,582 for the three months ended September 30, 2019. This is mainly due to the decrease in ASP of offset printing paper. We sold 10,280 tonnes of offset printing paper in the third quarter of 2020, as compared to 10,198 tonnes in the comparable period of 2019, an increase of 82 tonnes, or 0.80%. ASPs for offset printing paper for the third quarter of 2019 and 2020 were $690 and $596, respectively, representing a 13.62% decrease. ASP in RMB for offset printing paper for the third quarter of 2019 and 2020 was RMB4,779 and RMB4,159, respectively, representing a 12.97% decrease.

#### Revenue of Face Mask

On April 29, 2020, we launched a production line of non-medical single-use face masks, following the completion of raw materials preparation, trial run of the equipment and the sample products inspection. Revenue generated from selling face masks were $221,102 for the three months ended September 30, 2020. We sold 3,576 thousand pieces of face masks in the third quarter of 2020.

Cost of Sales

Total cost of sales for CMP, offset printing paper and tissue paper products for the quarter ended September 30, 2020 was $30,593,395, an increase of $3,030,210, or 10.99%, from $27,563,185 for the comparable period in 2019. This was mainly due to the increase in material costs.

Cost of sales for CMP was $22,898,910 for the quarter ended September 30, 2020, as compared to $20,711,656 for the comparable period in 2019. The increase in the cost of sales of $2,187,254 for CMP was mainly due to the increase in average cost of sales. Average cost of sales per tonne for CMP increased by 9.01%, from $344 in the third quarter of 2019 to $375 in the third quarter of 2020. The increase in average cost of sales was mainly attributable to the higher average unit purchase costs (net of applicable value added tax) of recycled paper board in third quarter of 2020 compared to the third quarter of 2019.

Cost of sales for offset printing paper was $4,969,350 for the quarter ended September 30, 2020, as compared to $4,696,459 for the comparable period in 2019. Average cost of sales per tonne of offset printing paper increased by 4.77%, from $461 in the three months ended September 30, 2019, to $483 during the comparable period in 2020. The increase in average cost of sales of offset printing paper was mainly due to the increase in average unit purchase costs(net of applicable value added tax) of recycled white scrap paper.

Cost of sales for tissue paper products was $2,725,135 for the quarter ended September 30, 2020, as compared to $2,155,070 for the comparable period in 2019. The increase in the cost of sales of $570,065 for tissue paper products was mainly due to the increase in sales volume of tissue paper products, partially offset by the decrease in average cost of sales. Average cost of sales per tonne of tissue paper products decreased by 18.45%, from $1,171 in the three months ended September 30, 2019, to $955 for the comparable period in 2020. This is mainly due to the decrease in cost of tissue base paper.

Changes in cost of sales and cost per tonne by product for the quarters ended September 30, 2020 and 2019 are summarized below:

|  | Three Months Ended September 30, 2020 Cost of Sales | Cost per Tonne | Three Months Ended September 30, 2019 Cost of Sales | Cost per Tonne | Change in Cost of Sales | Cost per Tonne | Change in percentage Cost of Sales | Cost per Tone |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Regular CMP | $18,301,720 | $380 | $16,493,658 | $347 | $1,808,062 | $33 | 10.96% | 9.51% |
| Light-Weight CMP | $4,597,190 | $357 | $4,217,998 | $332 | $379,192 | $25 | 8.99% | 7.53% |
| **Total CMP** | $22,898,910 | $375 | $20,711,656 | $344 | $2,187,254 | $31 | 10.56% | 9.01% |
| Offset Printing Paper | $4,969,350 | $483 | $4,696,459 | $461 | $272,891 | $22 | 5.81% | 4.77% |
| Tissue Paper Products | $2,725,135 | $955 | 2,155,070 | $1,171 | $570,065 | $(216) | 26.45% | -18.45% |
| **Total CMP, Offset Printing Paper and Tissue Paper** | $30,593,395 | $ n/a | $27,563,185 | $n/a | $3,030,210 | $n/a | 10.99% | n/a |

Our average unit purchase costs (net of applicable value added tax) of recycled paper board and recycled white scrap paper in the three months ended September 30, 2020 were RMB 1,754/tonne (approximately $251/tonne) and RMB 2,078/tonne (approximately $297/tonne), as compared to RMB 1,372/tonne (approximately $200/tonne) and RMB 1,770/tonne (approximately $258/tonne) for the three months ended September 30, 2019. These changes (in US dollars) represent a year-over-year increase of 25.50% for the recycled paper board. We use domestic recycled paper (sourced mainly from the Beijing-Tianjin metropolitan area) exclusively. Although we do not rely on imported recycled paper, the pricing of which tends to be more volatile than domestic recycled paper, our experience suggests that the pricing of domestic recycled paper bears some correlation to the pricing of imported recycled paper.

The pricing trends of our major raw materials for the 24-month period from October 2018 to September 2020 are shown below:

Electricity and gas are our two main energy sources. Electricity and gas accounted for approximately 4% and 10.9% of total sales in the third quarter of 2020, respectively, compared to 5% and 10.4% of total sales in the third quarter of 2019. The monthly energy cost as a percentage of total monthly sales of our main paper products for the 24 months ended September 30, 2020 are summarized as follows:

#### Gross Profit

Gross profit for the three months ended September 30, 2020 was $2,567,551 (7.70% of the total revenue), representing a decrease of $2,807,181, or 52.23%, from the gross profit of $5,374,732 (16.32% of the total revenue) for the three months ended September 30, 2019, as a result of factors described above.

#### Offset Printing Paper, CMP and Tissue Paper Products

Gross profit for offset printing paper, CMP and tissue paper products for the three months ended September 30, 2020 was $2,542,954, a decrease of $2,831,778, or 52.69%, from the gross profit of $5,374,731 for the three months ended September 30, 2019. The decrease was mainly the result of the factors discussed above.

The overall gross profit margin for offset printing paper, CMP and tissue paper products decreased by 8.65 percentage points, from 16.32% for the three months ended September 30, 2019, to 7.67% for the three months ended September 30, 2020.

Gross profit margin for regular CMP for the three months ended September 30, 2020 was 6.40%, or 8.28 percentage points lower, as compared to gross profit margin of 14.68% for the three months ended September 30, 2019. Such decrease was mainly due to the increase in cost of recycled paper board in the third quarter of 2020.

Gross profit margin for light-weight CMP for the three months ended September 30, 2020 was 9.44%, or 6.49 percentage points lower, as compared to gross profit margin of 15.93% for the three months ended September 30, 2019. The decrease was mainly due to the increase in cost of recycled paper board in the third quarter of 2020.

Gross profit margin for offset printing paper was 18.89% for the three months ended September 30, 2020, a decrease of 14.38 percentage points, as compared to 33.27% for the three months ended September 30, 2019. The decrease was mainly due to the increase in cost of recycled white scrap paperand decrease in ASP of offset printing paper.

Gross profit margin for tissue paper products for the three months ended September 30, 2020 was -14.50%, or 24.42 percentage points higher, as compared to gross profit margin of -38.92% for the three months ended September 30, 2019. The increase was mainly due to increase in sales volume and decrease in cost of base paper, partially offset by decrease in ASP of tissue paper products in the third quarter of 2020.

Monthly gross profit margins on the sales of our CMP and offset printing paper for the 24-month period ended September 30, 2020 are as follows:

#### Face Masks

Gross profit for face masks for the three months ended September 30, 2020 was $24,598, representing a gross margin of 11.13%.

#### Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended September 30, 2020 were $2,390,920, an increase of $366,373, or 18.10% from $2,024,547 for the three months ended September 30, 2019. The increase was mainly due to additional expenditure on investment relation activities (e.g. consultancy, board meeting etc.) in the third quarter of 2020 and reversal of over-provision of lease expenses for the lands of Heibei Tengsheng in the third quarter of 2019.

#### Income (Loss) from Operations

Operating income for the quarter ended September 30, 2020 was $176,631, a decrease of $3,172,675, or 94.73%, from $3,349,306 for the quarter ended September 30, 2019. The decrease in income from operations was primarily due to the decrease in gross profit and increase in selling, general and administrative expenses.

#### Other Income and Expenses

Interest expense for the three months ended September 30, 2020 increased by $21,451, from $236,987 in the three months ended September 30, 2019, to $258,438. The Company had short-term and long-term interest-bearing loans, related party loans and leasing obligations that aggregated $16,060,576 as of September 30, 2020, as compared to $15,495,765 as of September 30, 2019.

#### Net Income (Loss)

As a result and the factors discussed above, net loss was $520,974 for the quarter ended September 30, 2020, representing a decrease of $2,859,001, or 122.28%, from net income of $2,338,027 for the quarter ended September 30, 2019.

### Comparison of the nine months ended September 30, 2020 and 2019

Revenue for the nine months ended September 30, 2020 was $68,463,575, a decrease of $15,544,582, or 18.5%, from $84,008,157 for the same period in the previous year.

#### Revenue of Offset Printing Paper, Corrugating Medium Paper and Tissue Paper Products

Revenue from sales of offset printing paper, CMP and tissue paper products for the nine months ended September 30, 2020 was $67,396,920, a decrease of $16,611,237, or 19.77%, from $84,008,157 for the nine months ended September 30, 2019. This was mainly due to the decrease in sales volume of Regular CMP and offset printing paper and the decrease in ASP of CMP, offset printing paper and tissue paper products. Total quantities of offset printing paper, CMP and tissue paper products sold during the nine months ended September 30, 2020 amounted to 158,644 tonnes, a decrease of 19,312 tonnes, or 10.85%, compared to 177,956 tonnes sold during the nine months ended September 30, 2019. Total quantities of CMP and offset printing paper sold decreased by 21,538 tonnes in the nine months of 2020 as compared to the same period of 2019. We sold 6,923 tonnes of tissue paper products in the nine months of 2020 as opposed to 4,697 tonnes in the same period of 2019. CMP production was suspended in mid-January to early March 2020 due to Chines New Yearand COVID-19 outbreak. We resumed full capacity of CMP production in May 2020. The production of offset printing paper was suspended duringJanuary to May 2020 and resumed in June 2020. The changes in revenue and quantity sold for the nine months ended September 30, 2020 and 2019 are summarized as follows:

A summary of the above changes and further analyses of the changes in our sales revenue are as follows:

| Sales Revenue | Nine Months Ended September 30, 2020 Quantity (Tonne) | Amount | Nine Months Ended September 30, 2019 Quantity (Tonne) | Amount | Change in Quantity (Tonne) | Amount | Percentage Change Quantity | Amount |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Regular CMP | 108,874 | $42,647,898 | 121,774 | $52,440,243 | (12,900) | $(9,792,345) | -10.59% | -18.67% |
| Light-Weight CMP | 30,384 | $11,594,324 | 32,728 | $13,692,911 | (2,344) | $(2,098,587) | -7.16% | -15.33% |
| **Total CMP** | 139,258 | $54,242,222 | 154,502 | $66,133,154 | (15,244) | $(11,890,932) | -9.87% | -17.98% |
| Offset Printing Paper | 12,463 | $7,388,491 | 18,757 | $13,274,547 | (6,294) | $(5,886,056) | -33.56% | -44.34% |
| Tissue Paper Products | 6,923 | $5,766,207 | 4,697 | 4,600,456 | 2,226 | $1,165,751 | 47.39% | 25.34% |
| **Total CMP, Offset Printing Paper and Tissue Paper Revenue** | 158,644 | $67,396,920 | 177,956 | $84,008,157 | (19,312) | $(16,611,237) | -10.85% | -19.77% |

33

ASPs for our main products in the six-month period ended September 30, 2020 and 2019 are summarized as follows:

|  | Offset Printing Paper ASP | Regular CMP ASP | Light-Weight CMP ASP | Tissue Paper Products ASP |
| --- | ---: | ---: | ---: | ---: |
| Nine Months Ended September 30, 2019 | $708 | $431 | $418 | $979 |
| Nine Months Ended September 30, 2020 | $593 | $392 | $382 | $833 |
| Decrease from comparable period in the previous year | $-115 | $-39 | $-36 | $-146 |
| Decrease by percentage | -16.24% | -9.05% | -8.61% | -14.91% |

#### Revenue of Face Mask

Revenue generated from selling face mask were $1,066,654 for the nine months ended September 30, 2020. We sold 9,856 thousand pieces of face masks in the third quarter of 2020.

#### Cost of Sales

Total cost of sales for CMP, offset printing paper and tissue paper products in the nine months ended September 30, 2020 was $62,968,256, a decrease of $12,949,506, or 17.06%, from $75,917,762 for the nine months ended September 30, 2019. This was mainly a result of the decrease in volume sold, partially offset by decrease in cost of materials. Cost of sales for CMP was $49,838,234 for the nine months ended September 30, 2020, as compared to $60,759,533 in the same period of 2019. The decrease in the cost of sales of $10,921,299 for CMP was mainly due to the decrease in the quantities of regular CMP sold, partially offset by the decrease in cost of recycled paper board in the nine months of 2020. Average cost of sales per tonne for CMP decreased by 8.91%, from $393 for the nine months ended September 30, 2019, to $358 in the same period of 2020. The decrease was mainly attributable to the lower average unit purchase costs (net of applicable value added tax) of recycled paper board. Cost of sales for offset printing paper was $5,932,881 for the nine months ended September 30, 2020, as compared to $9,313,615 in the same period of 2019. Average cost of sales per tonne of offset printing paper decreased by 4.23%, from $497 for the nine months ended September 30, 2019, to $476 in the same period of 2020.Cost of sales for tissue paper products was $7,197,141 for the nine months ended September 30, 2020, as compared to $5,844,614 in the same period of 2019. Average cost of sales per tonne of tissue paper products decreased by 16.40%, from $1,244 for the nine months ended September 30, 2019, to $1,040 for the same period of 2020.

Changes in cost of sales and cost per tonne by product for the nine months ended September 30, 2020 and 2019 are summarized below:

|  | Nine Months Ended September 30, 2020 Cost of Sales | Cost per Tonne | Nine Months Ended September 30, 2019 Cost of Sales | Cost per tonne | Change in Cost of Sales | Cost per Tonne | Change in percentage Cost of Sales | Cost per Tone |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Regular CMP | $39,545,909 | $363 | $48,038,937 | $394 | $(8,493,028) | $(31) | -17.68% | -7.87% |
| Light-Weight CMP | $10,292,325 | $339 | $12,720,596 | $389 | $(2,428,270) | $(50) | -19.09% | -12.85% |
| **Total CMP** | $49,838,234 | $358 | $60,759,533 | $393 | $(10,921,299) | $(35) | -17.97% | -8.91% |
| Offset Printing Paper | $5,932,881 | $476 | $9,313,615 | $497 | $(3,380,734) | $(21) | -36.30% | -4.23% |
| Tissue Paper Products | $7,197,141 | $1,040 | $5,844,614 | $1,244 | 1,352,527 | $(204) | 23.14% | -16.40% |
| **Total CMP, Offset Printing Paper and Tissue Paper Revenue** | $62,968,256 | $n/a | $75,917,762 | $n/a | $(12,949,506) | $n/a | -17.06% | n/a% |

34

#### Gross Profit

Gross profit for the nine months ended September 30, 2020 was $4,956,662 (7.24% of the total revenue), representing a decrease of $3,133,733, or 38.73%, from the gross profit of $8,090,395 (9.63% of the total revenue) for the nine months ended September 30, 2019. The decrease was mainly due to (i) the decrease in quantities sold of CMP and offset printing paper and (ii) the decrease of ASP of CMP, offset printing paper and tissue paper products, partially offset by the decrease of material purchase price of CMP and tissue paper products.

#### Offset Printing Paper, CMP and Tissue Paper Products

Gross profit for offset printing paper, CMP and tissue paper products for the nine months ended September 30, 2020 was $4,428,664, a decrease of $3,661,731, or 45.26%, from the gross profit of $8,090,395 for the nine months ended September 30, 2019. The decrease was mainly the result of the factors discussed above.

The overall gross profit margin for offset printing paper, CMP and tissue paper products decreased by 3.06 percentage points, from 9.63% for the nine months ended September 30, 2019, to 6.57% for the nine months ended September 30, 2020.

Gross profit margin for regular CMP for the nine months ended September 30, 2020 was 7.27%, or 1.12 percentage points lower, as compared to gross profit margin of 8.39% for the nine months ended September 30, 2019. Such decrease was primarily due to decrease of decrease in ASPof regular CMP, partially offset by the decrease in material purchase price.

Gross profit margin for light-weight CMP for the nine months ended September 30, 2020 was 11.23%, or 4.13 percentage points higher, as compared to gross profit margin of 7.10% for the nine months ended September 30, 2019.

Gross profit margin for offset printing paper was 19.70% for the nine months ended September 30, 2020, a decrease of 10.14 percentage points, as compared to 29.84% for the nine months ended September 30, 2019. Such decrease was mainly due to the decrease in ASP of offset printing paper.

Gross profit margin for tissue paper products was -24.82% for the nine months ended September 30, 2020, an increase of 2.22 percentage points, as compared to -27.04% for the nine months ended September 30, 2019.

#### Face Masks

Gross profit for face masks for the nine months ended September 30, 2020 was $527,997, representing a gross margin of 49.5%.

#### Selling, General and Administrative Expenses

Selling, general and administrative expenses for the nine months ended September 30, 2020 were $8,445,356, an increase of $1,031,477, or 13.91% from $7,413,879 for the nine months ended September 30, 2019. The increase was net impact ofthe issuance of 2,000,000 shares of common stock valued at $1,200,000 to officers, directors and employees andthe issuance of 60,000 shares of common stock valued at $42,000 to a consultant and a decrease in sales commission to staff.

#### Income (Loss) from Operations

Operating loss for the nine months ended September 30, 2020 was $3,488,694, a decrease of $4,195,728, or 593.43%, from income from operations of $707,034 for the nine months ended September 30, 2019. The decrease was primarily due to the decrease in gross profit and the increase in selling, general and administrative expenses.

#### Other Income and Expenses

Interest expense for the nine months ended September 30, 2020 increased by $13,565, from $731,027 for the nine months ended September 30, 2019, to $744,592. The Company had short-term and long-term interest-bearing loans and lease obligation that aggregated $16,060,576 as of September 30, 2020, as compared to $15,495,765 as of September 30, 2019.

#### Net Loss

As a result of the above, net loss was $3,937,292 for the nine months ended September 30, 2020, representing a decrease of $4,002,794, or 6110.95%, from net income of $65,502 for nine months ended September 30, 2019.

#### Accounts Receivable

Net accounts receivable increased by $353,063, or 11.32%, to $3,472,374 as of September 30, 2020, as compared with $3,119,311 as of December 31, 2019. We usually collect accounts receivable within 30 days of delivery and completion of sales.

#### Inventories

Inventories consist of raw materials (accounting for 80.81% of total value of inventory as of September 30, 2020), semi-finished goods and finished goods. As of September 30, 2020, the recorded value of inventory increased by 433.94% to $8,582,912 from $1,607,463 as of December 31, 2019. As of September 30, 2020, the inventory of recycled paper board, which is the main raw material for the production of CMP, was $5,512,274, approximately $5,472,242, or 13669.67%, higher than the balance as of December 31, 2019. Due to the volatility of recycled paper board and recycled white scrap paper prices, a minimum level of inventory was maintained at the end of 2019.

A summary of changes in major inventory items is as follows:

| Raw Materials | September 30, 2020 | December 31, 2019 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Recycled paper board | $5,512,274 | $40,032 | 5,472,242 | 13669.67% |
| Recycled white scrap paper | 1,016,905 | 10,541 | 1,006,364 | 9547.14% |
| Tissue base paper | 148,573 | 122,648 | 25,925 | 21.14% |
| Gas | 46,891 | 41,675 | 5,216 | 12.52% |
| Mask fabric and other raw materials | 210,914 | 171,287 | 39,627 | 23.13% |
| Total Raw Materials | 6,935,557 | 386,183 | 6,549,374 | 1695.93% |
| Semi-finished Goods | 145,069 | 83,266 | 61,803 | 74.22% |
| Finished Goods | 1,502,286 | 1,212,849 | 289,437 | 23.86% |
| Total inventory, gross | 8,582,912 | 1,682,298 | 6,900,614 | 410.19% |
| Inventory reserve | - | (74,835) | 74,835 | -100.00% |
| **Total inventory, net** | $8,582,912 | $1,607,463 | 6,975,449 | 433.94% |

36

#### Renewal of operating lease

On August 7, 2013, the Company’s Audit Committee and the Board of Directors approved the sale of the land use right of the Headquarters Compound (the “LUR”), the office building and essentially all industrial-use buildings in the Headquarters Compound (the “Industrial Buildings”), and three employee dormitory buildings located within the Headquarters Compound (the “Dormitories”) to Hebei Fangsheng for cash prices of approximately $2.77 million, $1.15 million, and $4.31 million respectively. In connection with the sale of the Industrial Buildings, Hebei Fangsheng agreed to lease the Industrial Buildings back to the Company for its original use for a term of up to three years, with an annual rental payment of approximately $143,078 (RMB1,000,000). The lease agreement expired in August 2016. On August 6, 2016 and August 6, 2018, the Company entered into two supplementary agreements with Hebei Fangsheng, who agreed to extend the lease term to August 9, 2022 with the same rental payment as provided for in the original lease agreement. The accrued rental owed to Hebei Fangsheng was $nil and $56,552 as of September 30, 2020 and December 31, 2019, respectively, and such amounts were recorded as part of the current liabilities.

#### Capital Expenditure Commitment as of September 30, 2020

On May 5, 2020, the Company announced it planned the commercial launch of a new tissue paper production line PM10 and the Company signed an agreement to purchase paper machine with paper machine supplier. The Company expected the new tissue paper production line to be launched after the completion of trial run.

As of September 30, 2020, we had approximately $4 million in capital expenditure commitments that were mainly related to the purchase of paper machine of PM10 and the improvement of Industrial Buildings. These commitments are expected to be financed by bank loans and cash flows generated from our business operations.

#### Financing with Sale-Leaseback

The Company entered into a sale-leaseback arrangement (the “Lease Financing Agreement”) with TAC Leasing Co., Ltd.(“TLCL”) on August 6, 2020, for a total financing proceeds in the amount of RMB 16 million (approximately US$2.3 million). Under the sale-leaseback arrangement, Hebei Tengsheng sold the Leased Equipment to TLCL for 16 million (approximately US$2.3 million). Concurrent with the sale of equipment, Hebei Tengsheng leases back the equipment sold to TLCL for a lease term of three years. At the end of the lease term, Hebei Tengsheng may pay a nominal purchase price of RMB 100 (approximately $15) to TLCL and buy back the Leased Equipment. The Leased Equipment in amount of $2,349,452 was recorded as right-of-use assets and the net present value of the minimum lease payments was recorded as lease liability and calculated with TLCL’s implicit interest rate of 15.6% per annum and stated at $567,099 at the inception of the lease on August 17, 2020.

Hebei Tengsheng made two payments due according to the schedule. As of September 30, 2020, the balance of Leased Equipment net of amortization was $2,336,399. The lease liability were $385,650 and its current portion in the amount of $168,546 as of September 30, 2020.

Amortization of the Leased Equipment was $12,718 for the three and nine months ended September 30, 2020. Total interest expenses for the sale-leaseback arrangement was $7,172 for the three and nine months ended September 30, 2020.

As a result of the sale and leaseback, a deferred gain in the amount of $430,695 was recorded. The deferred gain is amortized over the lease term and as an offset to amortization of the Leased Equipment.

#### Cash and Cash Equivalents

Our cash, cash equivalents and restricted cash as of September 30, 2020 was $8,209,905, an increase of $2,372,160, from $5,837,745 as of December 31, 2019. The increase of cash and cash equivalents for the nine months ended September 30, 2020 was attributable to a number of factors:

#### i. Net cash provided by operating activities

Net cash provided by operating activities was $2,369,487 for the nine months ended September 30, 2020. The balance represented a decrease of cash of $2,229,547, or 48.48%, from $4,599,034 provided for the nine months ended September 30, 2019. Net loss for the nine months ended September 30, 2020 was $3,937,292, representing a decrease of $4,002,794, or 6110.95%, from a net income of $65,502 for the nine months ended September 30, 2019. Changes in various asset and liability account balances throughout the nine months ended September 30, 2020 also contributed to the net change in cash from operating activities in nine months ended September 30, 2020. Chief among such changes is the increase of accounts receivable in the amount of $272,857 during the nine months of 2020. There was also an increase of $6,758,500 in the ending inventory balance as of September 30, 2020 (a decrease to net cash for the nine months ended September 30, 2020 cash flow purposes). In addition, the Company had non-cash expenses relating to depreciation and amortization in the amount of $11,301,703. The Company also had a net decrease of $2,099,669 in prepayment and other current assets (an increase to net cash) and a net decrease of $432,206 in other payables and accrued liabilities and related parties (an increase to net cash), as well as a decrease in income tax payable of $795,487 (a decrease to net cash) during the nine months ended September 30, 2020.

#### ii. Net cash used in investing activities

We incurred $2,571,949 in net cash expenditures for investing activities during the nine months ended September 30, 2020, as compared to $6,449,181 for the same period of 2019. Payments in the nine months ended September 30, 2020 were for the payment of Heibei Tengsheng acquisition, PM10 paper machine and expenditures on improvement of Industrial Buildings.

#### iii. Net cash provided by financing activities

Net cash provided by financing activities was proceeds from issuance of shares and warrants and repayment of lease liability of $2,241,043 for the nine months ended September 30, 2020, as compared to net cash used in financing activities in the amount of $5,224,295 for the nine months ended September 30, 2019.

| Short-term bank loans | September 30, 2020 | December 31, 2019 |
| --- | ---: | ---: |
| Industrial and Commercial Bank of China (“ICBC”) Loan 1 | $6,314,151 | $6,163,814 |
| Total short-term bank loans | $6,314,151 | $6,163,814 |

On December 20, 2019, the Company entered into a working capital loan agreement with the ICBC, with a balance of $6,314,151 and $6,163,814 as of September 30, 2020 and December 31, 2019, respectively. The working capital loan was secured by the Land use right of Dongfang Paper as collateral for the benefit of the bank. The loan bears a fixed interest rate of 4.785% per annum. The loan will be due and repaid by December 23, 2020.

As of September 30, 2020, there were guaranteed short-term borrowings of $6,314,151 and unsecured bank loans of $nil. As of December 31, 2019, there were guaranteed short-term borrowings of $6,163,814 and unsecured bank loans of $nil.

The average short-term borrowing rates for the three months ended September 30, 2020 and 2019 were approximately 4.79% and 4.77%, respectively. The average short-term borrowing rates for the nine months ended September 30, 2020 and 2019 were approximately 4.79% and 4.76%, respectively.

#### Long-term loans from credit union

As of September 30, 2020 and December 31, 2019, loans payable to Rural Credit Union of Xushui District, amounted to $9,192,229 and $8,973,367, respectively.

On April 16, 2014, the Company entered into a loan agreement with the Rural Credit Union of Xushui District for a term of 5 years, which was originally due in various installments from June 21, 2014 to November 18, 2018. The loan is guaranteed by an independent third party. Interest payment is due quarterly and bears the rate of 0.64% per month. On November 6, 2018, the loan was renewed for additional 5 years and will be due and payable in various installments from December 21, 2018 to November 5, 2023. As of September 30, 2020 and December 31, 2019, total outstanding loan balance was $1,262,830 and $1,232,763, respectively. Out of the total outstanding loan balance, current portion amounted were $176,209 and $143,345 as of September 30, 2020 and December 31, 2019, respectively, which are presented as current liabilities in the consolidated balance sheet and the remaining balance of $1,086,621 and $1,089,418 are presented as non-current liabilities in the consolidated balance sheet as of September 30, 2020 and December 31, 2019, respectively.

On July 15, 2013, the Company entered into a loan agreement with the Rural Credit Union of Xushui District for a term of 5 years, which was originally due and payable in various installments from December 21, 2013 to July 26, 2018. On June 21, 2018, the loan was extended for additional 5 years and will be due and payable in various installments from December 21, 2018 to June 20, 2023. The loan is secured by certain of the Company’s manufacturing equipment with net book value of $2,690,540 and $3,935,270 as of September 30, 2020 and December 31, 2019, respectively. Interest payment is due quarterly and bears a fixed rate of 0.64% per month. As of September 30, 2020 and December 31, 2019, the total outstanding loan balance was $3,671,018 and $3,583,613, respectively. Out of the total outstanding loan balance, current portion amounted were $249,629 and $172,013 as of September 30, 2020 and December 31, 2019, respectively, which are presented as current liabilities in the consolidated balance sheet and the remaining balance of $3,421,389 and $3,411,600 are presented as non-current liabilities in the consolidated balance sheet as of September 30, 2020 and December 31, 2019, respectively.

On April 17, 2019, the Company entered into a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which was due and payable in various installments from August 21, 2019 to April 16, 2021. The loan is secured by Hebei Tengsheng with its land use right as collateral for the benefit of the bank. Interest payment is due quarterly and bears a fixed rate of 0.6% per month. As of September 30, 2020 and December 31, 2019, the total outstanding loan balance was $2,349,452 and $2,293,512, respectively. Out of the total outstanding loan balance, current portion amounted were $2,349,452 and $1,146,756 as of September 30, 2020 and December 31, 2019, respectively, which are presented as current liabilities in the consolidated balance sheet and the remaining balance of $nil and $1,146,756 are presented as non-current liabilities in the consolidated balance sheet as of September 30, 2020 and December 31, 2019, respectively.

On December 12, 2019, the Company entered into a loan agreement with the Rural Credit Union of Xushui District for a term of 2 years, which is due and payable in various installments from June 21, 2020 to December 11, 2021. The loan is secured by Hebei Tengsheng with its land use right as collateral for the benefit of the bank. Interest payment is due monthly and bears a fixed rate of 7.56% per annum. As of September 30, 2020 and December 31, 2019, the total outstanding loan balance was $1,908,929 and $1,863,479, respectively. Out of the total outstanding loan balance, current portion amounted were $1,027,885 and $143,345 as of September 30, 2020 and December 31, 2019, respectively, which are presented as current liabilities in the consolidated balance sheet and the remaining balance of $881,044 and $1,720,134 are presented as non-current liabilities in the consolidated balance sheet as of September 30, 2020 and December 31, 2019, respectively.

Total interest expenses for the short-term bank loans and long-term loans for the three months ended September 30, 2020 and 2019 were $251,266 and $214,907, respectively. Total interest expenses for the short-term bank loans and long-term loans for the nine months ended September 30, 2020 and 2019 were $737,420 and $659,613, respectively.

#### Shareholder Loans

Mr. Zhenyong Liu, the Company’s CEO, has loaned money to Dongfang Paper for working capital purposes over a period of time. On January 1, 2013, Dongfang Paper and Mr. Zhenyong Liu renewed the three-year term loan previously entered on January 1, 2010, and extended the maturity date further to December 31, 2015. On December 31, 2015, the Company paid off the loan of $2,249,279, together with interest of $391,374 for the period from 2013 to 2015. Approximately $376,403 and $367,441 of interest were outstanding to Mr. Zhenyong Liu, which were recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet as of September 30, 2020 and December 31, 2019, respectively.

On December 10, 2014, Mr. Zhenyong Liu provided a loan to the Company, amounted to $8,483,083 to Dongfang Paper for working capital purpose with an interest rate of 4.35% per annum, which was based on the primary lending rate of People’s Bank of China. The unsecured loan was provided on December 10, 2014, and would be originally due on December 10, 2017. During the year of 2016, the Company repaid $6,012,416 to Mr. Zhenyong Liu, together with interest of $288,596. In February 2018, the Company paid off the remaining balance, together with interest of $20,400. As of September 30, 2020 and December 31, 2019, approximately $44,052 and $43,003 of interest were outstanding to Mr. Zhenyong Liu, which was recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

On March 1, 2015, the Company entered an agreement with Mr. Zhenyong Liu which allows Dongfang Paper to borrow from the CEO an amount up to $17,620,887 (RMB120,000,000) for working capital purposes. The advances or funding under the agreement are due three years from the date each amount is funded. The loan is unsecured and carries an annual interest rate set on the basis of the primary lending rate of the People’s Bank of China at the time of the borrowing. On July 13, 2015, an unsecured amount of $4,324,636 was drawn from the facility. On October 14, 2016, an unsecured amount of $2,883,091 was drawn from the facility. In February 2018, the Company repaid $1,507,432 to Mr. Zhenyong Liu. The loan would be originally due on July 12, 2018. Mr. Zhenyong Liu agreed to extend the loan for additional 3 years and the remaining balance will be due on July 12, 2021. On November 23, 2018, the Company repaid $3,768,579 to Mr. Zhenyong Liu, together with interest of $158,651. In December 2019, the Company paid off the remaining balance, together with interest of $94,636. As of September 30, 2020 and December 31, 2019, the outstanding loan balance were $nil and the accrued interest was $201,814 and $197,009, respectively, which was recorded in other payables and accrued liabilities as part of the current liabilities in the consolidated balance sheet.

As of September 30, 2020 and December 31, 2019, total amount of loans due to Mr. Zhenyong Liu were $nil. The interest expense incurred for such related party loans are $nil and $23,234 for the three months ended September 30, 2020 and 2019, respectively. The interest expenses incurred for such related party loans are $nil and $71,415 for the nine months ended September 30, 2020 and 2019, respectively. The accrued interest owed to Mr. Zhenyong Liu was approximately $622,269 and $607,453, as of September 30, 2020 and December 31, 2019, respectively, which was recorded in other payables and accrued liabilities.

As of September 30, 2020 and December 31, 2019, amount due to shareholder are $657,433 and $483,433, respectively, which represents funds from shareholders to pay for various expenses incurred in the U.S. The amount is due on demand with interest free.

### Critical Accounting Policies and Estimates

The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States, which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates. The most critical accounting policies are listed below:

#### Revenue Recognition Policy

The Company recognizes revenue when goods are delivered and a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist, and collectability is reasonably assured. Goods are considered delivered when the customer’s truck picks up goods at our finished goods inventory warehouse.

#### Long-Lived Assets

The Company evaluates the recoverability of long-lived assets and the related estimated remaining useful lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amount. In such circumstances, those assets are written down to estimated fair value. Our judgments regarding the existence of impairment indicators are based on market conditions, assumptions for operational performance of our businesses, and possible government policy toward operating efficiency of the Chinese paper manufacturing industry. For the three months ended September 30, 2020 and 2019, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required. We are currently not aware of any events or circumstances that may indicate any need to record such impairment in the future.

#### Foreign Currency Translation

The functional currency of Dongfang Paper and Baoding Shengde is the Chinese Yuan Renminbi (“RMB”). Under ASC Topic 830-30, all assets and liabilities are translated into United States dollars using the current exchange rate at the end of each fiscal period. The current exchange rates used by the Company as of September 30, 2020 and December 31, 2019 to translate the Chinese RMB to the U.S. Dollars are 6.8101:1 and 6.9762:1, respectively. Revenues and expenses are translated using the prevailing average exchange rates at 6.9892:1, and 6.7087:1 for the nine months ended September 30, 2020 and 2019, respectively. Translation adjustments are included in other comprehensive income (loss).

### Off-Balance Sheet Arrangements

We were the guarantor for Baoding Huanrun Trading Co., Ltd.(“Baoding Huanrun”) for its long-term bank loans in an amount of $4,552,062 (RMB31,000,000), which matures at various times in 2020 -2023. Baoding Huanrun is one of our major suppliers of raw materials. This arrangement helps us to maintain a good relationship with the supplier and negotiate for better terms in payment for materials. If Baoding Huanrun were to become insolvent, the Company could be materially adversely affected. Except as aforesaid, we have no material off-balance sheet transactions.

### Recent Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The amendments in this Update related to separate financial statements of legal entities that are not subject to tax should be applied on a retrospective basis for all periods presented. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments should be applied on a prospective basis. We do not expect the adoption of ASU 2019-12 to have a material impact on our condensed consolidated financial statements.

## Market risk

As filed, 1,407 characters.

### Foreign Exchange Risk

While our reporting currency is the US dollar, almost all of our consolidated revenues and consolidated costs and expenses are denominated in RMB. All of our assets are denominated in RMB except for some cash and cash equivalents and accounts receivables. As a result, we are exposed to foreign exchange risks as our revenues and results of operations may be affected by fluctuations in the exchange rate between US dollar and RMB. If the RMB depreciates against the US dollar, the value of our RMB revenues, earnings and assets as expressed in our US dollar financial statements will decline. We have not entered into any hedging transactions in an effort to reduce our exposure to foreign exchange risk.

### Inflation

Although we are generally able to pass along minor incremental cost inflation to our customers, inflation such as increases in the costs of our products and overhead costs may adversely affect our operating results. We do not believe that inflation in China has had a material impact on our financial position or results of operations to date, however, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling and distribution, general and administrative expenses as a percentage of net revenues if the selling prices of our products do not increase in line with the increased costs.

## Controls and procedures

As filed, 1,575 characters.

As required by Rule 13a-15 of the Securities Exchange Act, as amended (the “Securities Act”), we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures, which were designed to provide reasonable assurance of achieving their objectives. This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of September 30, 2020, our disclosure controls and procedures were effective at the reasonable assurance level to ensure (1) that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (2) information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

### Changes in Internal Control over Financial Reporting

There were no changes with respect to our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting in the quarterly period ended September 30, 2020.

## Risk factors

As filed, 163 characters.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Filed Nov 12, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-036390. Last ingested by Listed: Nov 12, 2026, 17:16 ET. No prices; not investment advice.
